We are live on ! Find out more
ICUI icon

ICU Medical

175.10 USD
0.00
0%
At close Updated Aug 28, 4:00 PM EDT
Pre-market
After hours
175.10
0.00
0%
1 day
0%
5 days
-5.04%
1 month
5.62%
3 months
26.09%
6 months
19.12%
Year to date
26.4%
1 year
37.83%
5 years
-12.5%
10 years
38.11%
 

About: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Employees: 13,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 46.2%
Neutral 53.8%
Negative 0%
Neutral
GlobeNewsWire
2 days ago
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences: Wells Fargo 21st Annual Healthcare Conference on September 9-10, 2026 Company management will attend the Wells Fargo 21st Annual Healthcare Conference, held at the Encore Boston Harbor in Boston, MA, participating in one-on-one meetings on Wednesday, September 9 and Thursday, September 10, 2026.
ICU Medical to Participate in Upcoming Investor Conferences
Positive
Benzinga
22 days ago
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.
ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings
Neutral
Seeking Alpha
23 days ago
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q2 2026 Earnings Call Transcript
Positive
MarketBeat
23 days ago
ICU Medical Q2 Earnings Call Highlights
ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
ICU Medical Q2 Earnings Call Highlights
Neutral
Zacks Investment Research
23 days ago
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
23 days ago
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $1.91 per share. This compares to earnings of $2.1 per share a year ago.
ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
23 days ago
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
SAN CLEMENTE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2026.
ICU Medical Announces Second Quarter 2026 Results and Updates its Fiscal Year 2026 Guidance
Neutral
GlobeNewsWire
1 month ago
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2026 earnings release and conference call.
ICU Medical Announces Time of Second Quarter 2026 Earnings Conference Call
Neutral
PRNewsWire
1 month ago
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
This expansion of IV solutions manufacturing will help enhance supply-chain resiliency, support portfolio development and advance non-DEHP innovation for the North American IV solutions market. Joint venture announces over $500M IV solutions manufacturing expansion in Austin, TX Expansion aimed at improving IV solutions supply resiliency and quality, and accelerating non-DEHP new product development in North America via fully automated technology First major milestone toward fulfilling the commitments of the joint venture finalized in May 2025 between ICU Medical, Inc. and Otsuka Pharmaceutical Factory America, Inc. AUSTIN, Texas, July 9, 2026 /PRNewswire/ -- Otsuka ICU Medical LLC today announced plans for an over $500 million expansion to its US IV solutions manufacturing through a new facility and significant upgrades to its existing operations in Austin, Texas.
Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America
Positive
Zacks Investment Research
1 month ago
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
ICUI vs. SYK: Which Stock Should Value Investors Buy Now?
Price charts implemented using Lightweight Charts™